What is the evidence in favor of low-dose statin therapy in 2008?

Coronary heart disease (CHD) remains a major cause of death in the United States, and despite continued improvements in cardiovascular care, CHD rates remain unacceptably high. Modification of cardiovascular risk factors is the major strategy for reducing coronary disease and clinical events. Lipid modification therapy has played an important role in cardiovascular risk reduction, and the 3-hydroxy-3-methylglutaryl coenzyme A reductase...